Global merger and acquisition (M&A) activity shattered all-time records in 2021, comfortably erasing the high-water mark that was set nearly 15 years ago, as an abundance of capital and sky-high valuations fueled frenetic levels of dealmaking.

The value of M&A globally topped $5 trillion for the first time ever, with volumes rising 63 percent to $5.63 trillion by Dec. 16, according to Dealogic data, easily surpassing the pre-financial-crisis record of $4.42 trillion in 2007.

“Corporate balance sheets are incredibly healthy, sitting on $2 trillion of cash in the US alone — and access to capital remains widely-available at historically low costs,” said Chris Roop who co-heads North America M&A at JPMorgan.

Technology and health care, which typically account for the biggest share of the M&A market, led the way again in 2021, driven partly by pent-up demand from last year when the pace of M&A activity fell to a three-year-low due to the global financial fallout from the COVID-19 pandemic.

Companies rushed to raise funds from stock or bond offerings, large corporates took advantage of booming equity markets to use their own stock as acquisition currency, while financial sponsors swooped on publicly listed companies.

Moreover, robust corporate earnings and an overall bright economic outlook gave chief executives the confidence to pursue large, transformative deals, despite potential headwinds such as inflationary pressures.

“Strong equity markets are a key driver of M&A. When stock prices are high, that usually corresponds with a positive economic outlook and high CEO confidence,” said Tom Miles, co-head of Americas M&A at Morgan Stanley.

Overall deal volumes in the United States nearly doubled to $2.61 trillion in 2021, according to Dealogic.

Dealmaking in Europe jumped 47 percent to $1.26 trillion, while Asia Pacific rose 37 percent to $1.27 trillion.

A number of the year’s biggest transactions — AT&T Inc’s $43 billion deal with Discovery Inc. and the $34 billion leveraged buyout of Medline Industries Inc. — were announced during the first half of the year. 

But the pace of dealmaking showed no signs of slowing in the second half.

Easy availability of financing drove private equity deals, with volumes more than doubling from last year to a record $985.2 billion, according to Dealogic.

“Investors are deploying cash at an unprecedented pace which means that, on a global basis, asset valuations have peaked to historic levels,” said Luigi de Vecchi, chairman of Europe, Middle East and Africa banking capital markets advisory at Citigroup.

After a year of lockdowns, Wall Street’s top investment banks pushed their dealmakers to meet more clients in person to win lucrative mandates to merge companies or defend them against raids by activist investors.

“This year we’re set to exceed $100 billion in global investment banking fees,” said Berthold Fuerst, Deutsche Bank’s global co-head of M&A.

“There has been unprecedented demand for almost every single investment banking product,” he said.

After the record-breaking year, bankers are now anticipating a bumper bonus round in early 2022.

Breaking up corporate empires and conglomerates also proved to be a lucrative business for investment banks.

In the second half of the year, General Electric, Johnson & Johnson and Toshiba were among large corporates that announced plans to split up their core businesses and spin off several units.

The dealflow is showing no sign of slowing down as companies and investors rush to sign deals ahead of possible interest rate hikes.

Borrowing costs are widely expected to inch up in the coming months with the US Federal Reserve indicating it will increase rates next year to combat soaring inflation. Nonetheless, bankers expect dealmaking activity to remain robust.

“I don’t think upward movement in interest rates alone is going to be the catalyst that sidetracks the M&A market,” said Morgan Stanley’s Miles.

For all the headwinds, the year ahead still offers plenty of opportunities as the market for special purpose acquisition companies (SPACs) has recently reopened, with new listings in Europe, after coming under regulatory scrutiny in the United States.

“With private equity and with the dry powder in the SPAC world we expect the momentum to continue well into 2022,” said Philipp Beck, head of EMEA M&A at UBS.